Skip to main content
Log in

Cefepime is more costeffective than ceftriaxone in patients with nursing home-acquired pneumonia not requiring hospitalisation,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Paladino JA, Eubanks DA, Adelman MH, Schentag JJ.Once-daily cefepime versus ceftriaxone for nursing home-acquired pneumonia. Journal of the American Geriatrics Society 55: 651-657, No. 5, May 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cefepime is more costeffective than ceftriaxone in patients with nursing home-acquired pneumonia not requiring hospitalisation,. Pharmacoecon. Outcomes News 533, 7 (2007). https://doi.org/10.1007/BF03296131

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03296131

Keywords

Navigation